ArticleClinical and experimental vaccine research2020

Autolysin (lytA) recombinant protein: a potential target for developing vaccines against pneumococcal infections.

Davoud Afshar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.